Regulatory PathRegulatory requirements compared

Active substance

Nicotine polacrilex

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
NIQUITIN 2MG MINT LOZENGE2 mgLozenge · Oral use24 BottleSAR 31.80Generic · PrescriptionGLAXOSMITHKLINE (GSK)Withdrawn by MAH · Not Marketed
NIQUITIN 2MG MINT LOZENGE2 mgLozenge · Oral use48 BottleSAR 47.30Generic · PrescriptionGLAXOSMITHKLINE (GSK)Withdrawn by MAH · Not Marketed
NIQUITIN 4MG MINT LOZENGE4 mgLozenge · Oral use24 BottleSAR 31.80Generic · PrescriptionGLAXOSMITHKLINE (GSK)Withdrawn by MAH · Not Marketed
NIQUITIN 4MG MINT LOZENGE4 mgLozenge · Oral use48 BottleSAR 47.30Generic · PrescriptionGLAXOSMITHKLINE (GSK)Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
NICORETTEEQ 2MG BASEgum, chewing · buccalHALEON US HOLDINGSOver-the-counter13 Jan 1984
NICORETTE (MINT)EQ 2MG BASEgum, chewing · buccalHALEON US HOLDINGSOver-the-counter13 Jan 1984
NICORETTEEQ 4MG BASEgum, chewing · buccalHALEON US HOLDINGSOver-the-counter8 Jun 1992
NICORETTE (MINT)EQ 4MG BASEgum, chewing · buccalHALEON US HOLDINGSOver-the-counter8 Jun 1992
NICOTINE POLACRILEXEQ 2MG BASEgum, chewing · buccalP AND LOver-the-counter15 Mar 1999
NICOTINE POLACRILEXEQ 4MG BASEgum, chewing · buccalP AND LOver-the-counter19 Mar 1999
NICORETTEEQ 2MG BASE; EQ 4MG BASEtroche/lozenge · oralHALEON US HOLDINGSOver-the-counter31 Oct 2002
NICOTINE POLACRILEXEQ 4MG BASEgum, chewing · buccalP AND LOver-the-counter29 Jul 2004
NICOTINE POLACRILEXEQ 2MG BASEgum, chewing · buccalP AND LOver-the-counter29 Jul 2004
NICOTINE POLACRILEXEQ 2MG BASEgum, chewing · buccalL PERRIGO COOver-the-counter16 Sep 2004
NICOTINE POLACRILEXEQ 2MG BASEgum, chewing · buccalL PERRIGO COOver-the-counter16 Sep 2004
NICOTINE POLACRILEXEQ 4MG BASEgum, chewing · buccalL PERRIGO COOver-the-counter16 Sep 2004
NICOTINE POLACRILEXEQ 4MG BASEgum, chewing · buccalL PERRIGO COOver-the-counter16 Sep 2004
NICOTINE POLACRILEXEQ 2MG BASE; EQ 4MG BASEtroche/lozenge · oralPERRIGO R AND DOver-the-counter31 Jan 2006
NICOTINE POLACRILEXEQ 2MG BASEgum, chewing · buccalPERRIGO R AND DOver-the-counter30 Oct 2006
NICOTINE POLACRILEXEQ 4MG BASEgum, chewing · buccalPERRIGO R AND DOver-the-counter30 Oct 2006
NICOTINE POLACRILEXEQ 4MG BASEgum, chewing · buccalPERRIGO R AND DOver-the-counter24 May 2007
NICOTINE POLACRILEXEQ 2MG BASEgum, chewing · buccalPERRIGO R AND DOver-the-counter24 May 2007
NICOTINE POLACRILEXEQ 4MG BASEgum, chewing · buccalP AND LOver-the-counter29 Dec 2008
NICOTINE POLACRILEXEQ 2MG BASEgum, chewing · buccalP AND LOver-the-counter29 Dec 2008
NICORETTEEQ 2MG BASE; EQ 4MG BASEtroche/lozenge · oralHALEON US HOLDINGSOver-the-counter18 May 2009
NICOTINE POLACRILEXEQ 4MG BASEgum, chewing · buccalP AND LOver-the-counter8 Jul 2009
NICOTINE POLACRILEXEQ 2MG BASEgum, chewing · buccalP AND LOver-the-counter8 Jul 2009
NICOTINE POLACRILEXEQ 2MG BASEgum, chewing · buccalP AND LOver-the-counter8 Jul 2009
NICOTINE POLACRILEXEQ 4MG BASEgum, chewing · buccalP AND LOver-the-counter8 Jul 2009

35 more — full table

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.